Drug intelligence / Profile preview

avanafil + dapoxetine

Development stage
Unknown
Lead developer
Healing Pharma India
Modality
Small Molecules
Administration
Oral
01

Overview

Avadaforce is a combination pharmaceutical product containing avanafil and dapoxetine. Avanafil is a selective phosphodiesterase type 5 (PDE5) inhibitor that facilitates penile erection by increasing blood flow through the inhibition of cGMP degradation. Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation by increasing the time to ejaculation and improving control over ejaculation. This combination is typically used to treat male sexual dysfunction involving both erectile dysfunction and premature ejaculation.

Brand names
Avadaforce
Other names
avanafil/dapoxetine
02

Targets

PDE5 (Phosphodiesterase 5A)DAT (Dopamine plasma membrane transport protein)Kir (Inward-rectifier potassium channels)PDE6 (Phosphodiesterase 6)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on avanafil + dapoxetine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on avanafil + dapoxetine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call